Injectable hydrogels for localized chemotherapy and radiotherapy in brain tumors
P de la Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2018 - Elsevier
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
[PDF][PDF] INJECTABLE HYDROGELS FOR LOCALIZED CHEMO-AND RADIO-THERAPY IN BRAIN TUMORS
P de la Puente, N Fettig, MJ Luderer, A Jin, S Shah… - J Pharm Sci, 2018 - academia.edu
Purpose: Overall survival of patients with newly diagnosed glioblastoma (GBM) remains
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …
[HTML][HTML] INJECTABLE HYDROGELS FOR LOCALIZED CHEMO-AND RADIO-THERAPY IN BRAIN TUMORS
P de la Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2018 - ncbi.nlm.nih.gov
Purpose: Overall survival of patients with newly diagnosed glioblastoma (GBM) remains
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P de la Puente, N Fettig… - Journal of …, 2018 - utsouthwestern.elsevierpure.com
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P de la Puente, N Fettig, MJ Luderer… - Journal of …, 2018 - pure.johnshopkins.edu
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P de la Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2018 - profiles.wustl.edu
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P de la Puente, N Fettig, MJ Luderer… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P de la Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2018 - jpharmsci.org
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
P Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2018 - collections.uhsp.edu
Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16
months with state-of-the-art treatment that includes surgical resection, radiation, and …
months with state-of-the-art treatment that includes surgical resection, radiation, and …
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.
P Puente, N Fettig, MJ Luderer, A Jin… - Journal of …, 2017 - europepmc.org
Purpose: Overall survival of patients with newly diagnosed glioblastoma (GBM) remains
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …
dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation …